Imbruvica 140 mg (Ibrutinib)

✅ Key Benefits

• Targets BTK to impede B‑cell cancer cell survival

• Effective for CLL, mantle cell, Waldenström’s, and marginal zone lymphoma

• Oral daily dosing for outpatient therapy

• Demonstrated durable remission and progression delay

• Favorable safety profile with long-term tolerability

🎯 How to Use

• Adults: Typically 420 mg once daily for CLL/WM or 560 mg for mantle cell lymphoma, per physician direction

• Swallow capsules whole—do not open or chew

• Take with water at the same time each day

• Monitor blood counts, liver function, and cardiovascular status

• Store in a cool, dry place—keep out of children’s reach

⚠️ Precautions

• Prescription-only targeted therapy—use under specialist care

• Monitor for bleeding, atrial fibrillation, infections, and cytopenias

• Avoid concomitant anticoagulants or CYP3A4 modifiers

• Caution if pregnant or breastfeeding

• Discontinue and consult provider if severe infections, cardiac symptoms, or bleeding occur

🤕 Possible Side Effects

• Common: Diarrhea, fatigue, nausea, bruising, musculoskeletal pain

• Occasional: Hypertension, atrial fibrillation, cytopenias, infections

• Rare but serious: Major bleeding, cardiac arrhythmias, severe infections—seek medical care if observed

🎁 The Medicine Villa Special Offers

• 🏷️ Flat 50% OFF – Use Coupon Code: TMV50

• 🚚 Free USA Shipping on orders over $199

• 📦 USA to USA Delivery in 3–4 Days for eligible oncology items

• 🔒 Secure Checkout & Discreet Medical Packaging

❓ Frequently Asked Questions (FAQs)

Q. What is Imbruvica used for?
A. It’s indicated for CLL, mantle cell and marginal zone lymphomas, and Waldenström’s macroglobulinemia.

Q. When should Imbruvica be taken?
A. Once daily, as prescribed—usually 420 mg for CLL/WM; always at same time.

Q. Are lab tests needed during treatment?
A. Yes—monitor CBC, liver tests, and heart health regularly.

Q. Can I use Imbruvica if pregnant?
A. No—use contraception; avoid during pregnancy or breastfeeding.